共 36 条
[11]
2-T
[12]
COX JD, 1972, RADIOLOGY, V105, P63
[13]
A RANDOMIZED PHASE-I/II TRIAL OF HYPERFRACTIONATED RADIATION-THERAPY WITH TOTAL DOSES OF 60.0 GY TO 79.2 GY - POSSIBLE SURVIVAL BENEFIT WITH GREATER-THAN-OR-EQUAL-TO 69.6 GY IN FAVORABLE PATIENTS WITH RADIATION-THERAPY ONCOLOGY GROUP STAGE-III NON-SMALL-CELL LUNG-CARCINOMA - REPORT OF RADIATION-THERAPY ONCOLOGY GROUP 83-11
[J].
JOURNAL OF CLINICAL ONCOLOGY,
1990, 8 (09)
:1543-1555
[15]
RADIATION-THERAPY IN THE MANAGEMENT OF MEDICALLY INOPERABLE CARCINOMA OF THE LUNG - RESULTS AND IMPLICATIONS FOR FUTURE TREATMENT STRATEGIES
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
1992, 24 (01)
:3-9
[16]
Emami B, 1998, TREATMENT OPTIMIZATION FOR LUNG CANCER, P59
[17]
Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
1995, 33 (05)
:993-1000
[18]
Radiation-induced second cancers: The impact of 3D-CRT and IMRT
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2003, 56 (01)
:83-88
[19]
Randomized study of chemotherapy radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
1997, 38 (01)
:149-155
[20]
Impact of institutional experience on survival outcome of patients undergoing combined chemoradiation therapy for inoperable non-small-cell lung cancer
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2002, 52 (02)
:362-370